Continuing Medical Education (CME) Department Event Listing

1 - 5 of 5

The CAR-T Revolution 3 Years After FDA Approval

Torie CART

Three years after FDA approval of the first CAR-T therapy, Dr. Grupp will review outcomes data and provide an update on advancements and new trials in the field of cancer immunotherapy for patients with relapsed acute lymphoblastic leukemia (ALL).

Dec 15, 2020 from 5 p.m. - 6:30 p.m. (ET)

Cancer Predisposition and Surveillance in Children and Adolescents


During this webinar, we will present the general approach to patients with a possible cancer predisposition syndrome, review a few of the more common cancer surveillance syndromes, and discuss future directions in the field of pediatric cancer predisposition.

Jan 19, 2021 from 5:30 p.m. - 6:30 p.m. (ET)